ocument will contain important
information about the merger and should be read before any decision is made
with respect to the merger. Investors and stockholders will be able to
obtain free copies of this document and any other documents filed or
furnished by Evotec or Renovis through the website maintained by the
Securities and Exchange Commission at
http://www.sec.gov. Free copies of
these documents may also be obtained from Evotec, by directing a request to
Evotec's Investor Relations department at Schnackenburgallee 114, 22525
Hamburg, Germany, or from Renovis, by directing a request to Renovis'
Investor Relations department at Two Corporate Drive, South San Francisco,
California 94080.
In addition to the documents referenced above, Renovis files or
furnishes annual, quarterly and current reports, proxy statements and other
information with the Securities and Exchange Commission. You may read and
copy any reports, statements or other information filed or furnished by
Renovis at the SEC's Public Reference Room at Station Place, 100 F Street,
N.E., Washington, D.C. 20549. You can request copies of these documents by
writing to the SEC and paying a fee for the copying cost. Please call the
SEC at 1-800-SEC-0330 for more information about the operation of the
Public Reference Room. Renovis's SEC filings are also available to the
public at the SEC's web site at http://www.sec.gov, or at
http://www.renovis.com.
RENOVIS, INC.
Condensed Statements of Operations
(All amounts in thousands, except per share amounts)
(Unaudited)
Three Months Nine Months
Ended September 30, Ended September 30,
2007 2006 2007 2006
Contract revenue $1,31
'/>"/>
SOURCE Renovis, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
Renovis to Present at CIBC World Markets Healthcare Conference2.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound3.
QMed, Inc. Reports July Medicare SNP Enrollments4.
Phlo Affiliate Reports Expanded Coverage to Oregon Border5.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results6.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 20077.
Carrington Reports Second Quarter 2007 Results8.
Avitar Reports Third Quarter Financial Results for Fiscal 20079.
Response Genetics Reports Second Quarter 2007 Financial Results10.
Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results11.
Transgenomic, Inc. Reports Second Quarter 2007 Results